AGGRESSIVE OR EXPECTANT MANAGEMENT FOR PATIENTS WITH SEVERE PREECLAMPSIA BETWEEN 28-34 WEEKS GESTATION - A RANDOMIZED CONTROLLED TRIAL
- 1 December 1990
- journal article
- research article
- Vol. 76 (6) , 1070-1075
Abstract
Fifty-eight women with severe preeclampsia between 28-34 weeks'' gestation qualified for a randomized controlled trial to establish whether elective delivery 48 hours after administration of betamethasone (aggressive-management group) or delivery later as indicated by maternal or fetal condition (expectant-management group) was more beneficial to maternal and fetal outcome. Twenty women who qualified were not randomized because they developed maternal or fetal indications necessitating delivery within 48 hours; these newborns developed most of the complications. Expectant management was not associated with an increase in maternal complications, but it significantly prolonged the gestational age (mean 7.1 days; P < .05), reduced the number of neonates requiring ventilation (P < .05), and reduced the number of neonatal complications (P < .05).This publication has 5 references indexed in Scilit:
- Severe pre-eclampsia and infants of very low birth weight.Archives of Disease in Childhood, 1987
- Chronic Hypertension in PregnancyObstetrics & Gynecology, 1986
- PREGNANCY OUTCOME IN 303 CASES WITH SEVERE PREECLAMPSIA1984
- Fetal outcome in hypertensive disorders of pregnancyAmerican Journal of Obstetrics and Gynecology, 1982
- MANAGEMENT OF SEVERE TOXEMIA IN PATIENTS AT LESS THAN 36-WEEKS GESTATION1979